C-reactive protein and atherosclerosis: Quo vadis?

Italian Heart Journal

Volumn 2, Issue 11, 2001, Pages 801-803

  Koenig, W ^a   Torzewski, J ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Atherosclerosis; C reactive protein; Inflammation; Innate immunity

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; LIPID TRANSPORT; MACROPHAGE ACTIVATION; NEUTROPHIL CHEMOTAXIS; PROTEIN BLOOD LEVEL; THROMBOGENESIS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; HUMANS; RISK FACTORS;

EID: 0035669878     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses
2. C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons
3. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
4. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease
5. Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis CAPTURE Investigators
6. Independent prognostic value of elevated C-reactive protein in unstable angina
7. Enhanced inflammatory response in patients with preinfarction unstable angina
8. Atherosclerosis - An inflammatory disease
9. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
10. Coronary C-reactive protein distribution: Its relation to development of atherosclerosis
11. C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis
12. C-reactive protein mediates uptake of native low density lipoprotein by human macrophages
13. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein
14. C-reactive protein: Binding to lipids and lipoproteins
15. Immunohistochemical studies of C-reactive protein and apolipoprotein B in inflammatory and arterial lesions
16. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas
17. Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method
18. Complement activation by C-reactive protein complexes
19. Processes in atherogenesis: Complement activation
20. Complement activation and atherosclerosis
21. Regulation of complement activation by C-reactive protein
22. Regulation of phagocytic leukocyte activities by C-reactive protein
23. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling
24. Interaction of C-reactive protein with lymphocytes and monocytes: Complement-dependent adherence and phagocytosis
25. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II
26. Inflammation, pravastatin, and risk of coronary events after myocardial infarction in patients with average cholesterol levels
27. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
28. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
29. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
30. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction